Come up with a name for your new list and we'll add to it:
CytRx Corporation raised a round of funding on February 12, 2002. Investors include
Global Genomics Capital.
CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical devel…